Home » Topics » BioWorld Science

BioWorld Science
RSS

Engineered ACE2 protects against SARS-CoV-2 infection in vivo

Aug. 25, 2021

Regeneron reports topline phase II results on 8-mg dose of aflibercept in wet AMD

Aug. 24, 2021

BlueWillow announces interim phase I data on intranasal anthrax vaccine candidate BW-1010

Aug. 24, 2021

Biallelic mutations in DNAH10 cause male infertility with asthenoteratozoospermia

Aug. 24, 2021

Jupiter Wellness submits pre-IND meeting request for JW-100 for eczema

Aug. 24, 2021

Hepagene reports phase I data on FXR agonist HPG-1860

Aug. 24, 2021

JadiCells show promise in animal model of COPD

Aug. 24, 2021

Completed phase I studies of ME-3183 pave way for phase II studies in plaque psoriasis

Aug. 24, 2021

Bristol Myers Squibb identifies new lead BRD4 inhibitors

Aug. 24, 2021

Phase IIb study of izencitinib in ulcerative colitis misses primary endpoint

Aug. 24, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...